Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
10.10
-0.14 (-1.37%)
May 8, 2024, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PHAT stock have an average target of 22, with a low estimate of 10 and a high estimate of 28. The average target predicts an increase of 117.82% from the current stock price of 10.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PHAT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 2 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +157.43% | May 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +157.43% | May 3, 2024 |
| Stifel | Stifel | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +137.62% | May 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +157.43% | Apr 26, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +157.43% | Apr 19, 2024 |
Financial Forecast
Revenue This Year
45.71M
from 682.00K
Increased by 6,602.49%
Revenue Next Year
177.13M
from 45.71M
Increased by 287.50%
EPS This Year
-4.66
from -3.93
EPS Next Year
-3.27
from -4.66
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 56.6M | 249.2M | 557.5M | 601.0M | 819.2M |
| Avg | 45.7M | 177.1M | 389.7M | 532.0M | 795.2M |
| Low | 33.3M | 130.5M | 261.7M | 481.6M | 763.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8,198.4% | 445.2% | 214.7% | 54.2% | 54.0% |
| Avg | 6,602.5% | 287.5% | 120.0% | 36.5% | 49.5% |
| Low | 4,785.6% | 185.4% | 47.7% | 23.6% | 43.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.51 | -2.28 | 0.41 |
| Avg | -4.66 | -3.27 | -1.11 |
| Low | -5.82 | -4.07 | -2.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.